Clinical trial
Alleviant ALLAY-HFrEF Study
NCT06812533
Study timeline
Study start (actual)2025-03-10Date precision: day
Registry last updated2026-10-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureverified · MONDO: heart failure
Interventions
Alleviant ALV1 SystemDEVICE
Sham-ControlOTHER
Sponsors & collaborators
Alleviant Medical, Inc.lead sponsor
Mapped research locations
BostonMassachusetts, United States3BarcelonaSpain3Los AngelesCalifornia, United States2MadridSpain2MontrealQuebec, Canada2AustinTexas, United States2RochesterNew York, United States2CharlestonSouth Carolina, United States2AthensGreece2New YorkNew York, United States1St LouisMissouri, United States1San FranciscoCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06812533 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.